Aubrey Capital Management’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-62,400
Closed -$3.99M 56
2023
Q1
$3.99M Hold
62,400
2.31% 15
2022
Q4
$3.03M Sell
62,400
-3,100
-5% -$194K 2.43% 15
2022
Q3
$4.62M Hold
65,500
3.96% 6
2022
Q2
$4.65M Buy
65,500
+10,100
+18% +$651K 3.74% 9
2022
Q1
$4.43M Buy
55,400
+10,400
+23% +$775K 2.53% 14
2021
Q4
$4.11M Hold
45,000
1.6% 24
2021
Q3
$5.78M Buy
45,000
+8,900
+25% +$1.25M 1.82% 27
2021
Q2
$5.5M Buy
+36,100
New +$4.76M 1.6% 25
2018
Q4
Sell
-77,500
Closed -$3.72M 35
2018
Q3
$3.72M Hold
77,500
1.84% 22
2018
Q2
$2.42M Buy
+77,500
New +$1.81M 1.13% 33

Other funds holding STAA

Aubrey Capital Management's STAA Position: Q2 2023 in Review

Aubrey Capital Management sold out of STAAR Surgical (STAA) in Q2 2023, closing a stake of 62,400 shares — an estimated $3.99M sold.

Aubrey Capital Management first reported a position in STAA in Q2 2018 and held it in 10 quarters. The position peaked at $5.78M in Q3 2021. 245 funds tracked by Wall St. Rank hold STAA as of Q2 2023.

  • Aubrey Capital Management reported no remaining STAAR Surgical position as of Q2 2023 after selling out during the quarter.
  • Aubrey Capital Management sold 62,400 STAAR Surgical shares in Q2 2023, an estimated $3.99M.
  • Aubrey Capital Management first reported a position in STAAR Surgical in Q2 2018 and held it in 10 quarters.
  • Aubrey Capital Management's STAAR Surgical position peaked at $5.78M in Q3 2021.
  • 245 funds tracked by Wall St. Rank held STAAR Surgical as of Q2 2023.

Based on Aubrey Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.